New Eye Drop Formulation Based on Desonide and Xanthan Gum in Dry Eye Disease: Nonclinical Studies
<b>Background/Objectives:</b> A novel ophthalmic formulation, XanterDES, containing 0.2% xanthan gum and 0.025% desonide sodium phosphate (DES), was developed to alleviate ocular surface discomfort and irritation. This study aimed to evaluate its pharmacodynamic properties and to charact...
| Published in: | Pharmaceutics |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-02-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4923/17/2/235 |
